Skip to search.
 TSX Down 0.02% TSX Ventures Up 0.42%

Spectrum Pharmaceuticals, Inc. (SPPI)

-NasdaqGS
6.34 Up 0.03(0.48%) May 22, 4:00PM EDT
|After Hours : 6.34 0.00 (0.00%) May 22, 4:25PM EDT
Add to Portfolio
Prev Close:6.31
Open:6.32
Bid:6.09 x 300
Ask:7.00 x 100
1y Target Est:8.60
Beta:0.84
Earnings Date:Aug 5 - Aug 10 (Est.)
Day's Range:6.27 - 6.46
52wk Range:5.45 - 9.27
Volume:686,464
Avg Vol (3m):1,389,000
Market Cap:424.75M
P/E (ttm):N/A
EPS (ttm):-0.67
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SPPIUp 0.48%424.75M
BIIBDown 0.62%93.78B
RHHBYDown 0.94%N/A
TEVADown 0.60%51.77B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.28
Ex-Dividend Date:18-Dec-12

Analysts

Annual EPS Est (Dec-15) :-1.10
Quarterly EPS Est (Jun-15) :-0.24
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Spectrum Pharmaceuticals, Inc., a biotechnology company, develops and commercializes oncology and hematology drug products. The company markets five drug products, including FUSILEV for the treatment of patients with metastatic colorectal cancer, ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback